BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

759 related articles for article (PubMed ID: 35173728)

  • 1. Knowledge Mapping of Immunotherapy for Hepatocellular Carcinoma: A Bibliometric Study.
    Shen J; Shen H; Ke L; Chen J; Dang X; Liu B; Hua Y
    Front Immunol; 2022; 13():815575. PubMed ID: 35173728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bibliometric study of immunotherapy for hepatocellular carcinoma.
    Li Z; Zhang Y; Zhang B; Guo R; He M; Liu ZL; Yang L; Wang H
    Front Immunol; 2023; 14():1210802. PubMed ID: 37600802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telomerase-related advances in hepatocellular carcinoma: A bibliometric and visual analysis.
    Li HY; Zheng LL; Hu N; Wang ZH; Tao CC; Wang YR; Liu Y; Aizimuaji Z; Wang HW; Zheng RQ; Xiao T; Rong WQ
    World J Gastroenterol; 2024 Mar; 30(9):1224-1236. PubMed ID: 38577190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of global research trends and prospects on platinum-resistant ovarian cancer: a bibliometric analysis.
    Duan Y; Zhang P; Zhang T; Zhou L; Yin R
    Front Oncol; 2023; 13():1151871. PubMed ID: 37342181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knowledge mapping and current trends of immunotherapy for prostate cancer: A bibliometric study.
    Zhong W; Shen Z; Wu Y; Mao X; Kong J; Wu W
    Front Immunol; 2022; 13():1014981. PubMed ID: 36389756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bibliometric study on the knowledge graph of immunotherapy for head and neck cancer.
    Wang J; Gong Z; Yu M
    Front Oncol; 2023; 13():942777. PubMed ID: 36816940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A bibliometric study of the nasopharyngeal cancer immunotherapy knowledge map.
    Xie H; Liu W; Yang M
    Medicine (Baltimore); 2024 Apr; 103(16):e37763. PubMed ID: 38640273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in hepatocellular carcinoma research from 2008 to 2017: a bibliometric analysis.
    Miao Y; Zhang Y; Yin L
    PeerJ; 2018; 6():e5477. PubMed ID: 30128213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knowledge mapping of targeted immunotherapy for myasthenia gravis from 1998 to 2022: A bibliometric analysis.
    Su Y; Ruan Z; Wang R; Hao S; Tang Y; Huang X; Gao T; Li Z; Chang T
    Front Immunol; 2022; 13():998217. PubMed ID: 36248874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unveiling the Research Landscape and Emerging Trends in Cell Cycle for Cancer Immunotherapy: A Bibliometric Analysis (1990-2022).
    Feng C; Li Y; Zang M; Jin-Si-Han EE; He M; Lu Z
    Med Sci Monit; 2023 Dec; 29():e940556. PubMed ID: 38037303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging trends and research foci of oncolytic virotherapy for central nervous system tumors: A bibliometric study.
    Cheng K; Zhang H; Guo Q; Zhai P; Zhou Y; Yang W; Wang Y; Lu Y; Shen Z; Wu H
    Front Immunol; 2022; 13():975695. PubMed ID: 36148235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Research landscape and frontiers of non-alcoholic steatohepatitis-associated hepatocellular carcinoma: a bibliometric and visual analysis.
    Gao B; Chen Z; Shi M; Mo Y; Xiao H; Xie Y; Lin M; Chi X
    Front Pharmacol; 2023; 14():1240649. PubMed ID: 37771721
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunotherapy improves disease prognosis by affecting the tumor microenvironment: A bibliometric study.
    Wu X; Deng Z; Zhao Q
    Front Immunol; 2022; 13():967076. PubMed ID: 36275770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knowledge mapping of image-guided tumor ablation and immunity: A bibliometric analysis.
    Shen H; Wang L; Zhang Y; Huang G; Liu B
    Front Immunol; 2023; 14():1073681. PubMed ID: 36875115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative Review of Anesthesia in Liver Tumor Ablation: A Bibliometric Study from 1999 to 2022.
    Qu YD; Chen Z; Li X
    Med Sci Monit; 2023 Jun; 29():e939607. PubMed ID: 37277976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A bibliometric study on the utilization of lenvatinib in hepatocellular carcinoma (2014-2022).
    Wang CC; Yu CY; Zhang J; Wang R; Kong XS
    Front Pharmacol; 2023; 14():1159286. PubMed ID: 37388443
    [No Abstract]   [Full Text] [Related]  

  • 17. Knowledge mapping of immunotherapy in cervical carcinoma: a bibliometric analysis (2000-2023).
    Song L; Liang X; Zhu M; Su Q; Li F
    Front Immunol; 2023; 14():1328103. PubMed ID: 38264659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global research landscape and trends of papillary thyroid cancer therapy: a bibliometric analysis.
    Song B; Lin Z; Feng C; Zhao X; Teng W
    Front Endocrinol (Lausanne); 2023; 14():1252389. PubMed ID: 37795362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping research trends of transarterial chemoembolization for hepatocellular carcinoma from 2012 to 2021: A bibliometric analysis.
    Zhang N; He XF; Niu XK
    World J Methodol; 2023 Sep; 13(4):345-358. PubMed ID: 37771871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bibliometric Analysis of Chimeric Antigen Receptor-Based Immunotherapy in Cancers From 2001 to 2021.
    Ou Z; Qiu L; Rong H; Li B; Ren S; Kuang S; Lan T; Lin H; Li Q; Wu F; Cai T; Yan L; Ye Y; Fan S; Li J
    Front Immunol; 2022; 13():822004. PubMed ID: 35432345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.